Peter L. Salgo, MD: There are some newly approved classes of agents out there—human monoclonal antibodies, MAB treatments, that block the calcitonin gene-related peptide, CGRP. What is their mechanism ...

Peter Salgo, MD: Let’s take a look at some of the data for the prevention of episodic migraines. And I want to start by looking at the human monoclonal antibody treatment, or mAb treatments, to block ...

Neurologist Dr. Susan Lee answers common questions about new treatments for migraine and where the future of migraine research is headed. Standard treatments taken at the onset of a migraine episode ...

For Cherise Irons, chocolate, red wine, and aged cheeses are dangerous. So are certain sounds, perfumes and other strong scents, cold weather, and thunderstorms. Stress and lack of sleep, too. She ...

The approval of medicines called “CGRP antagonists” has led to big changes in how migraines are managed. These medicines work in a different way than older medicines to treat or prevent migraine. The ...

Hayley Gudgin of Sammamish, Wash., got her first migraine in 1991 when she was a 19-year-old nursing student. “I was convinced I was having a brain hemorrhage,” she says. “There was no way anything ...

CGRP inhibitors did not increase glaucoma risk in a large cohort of patients with migraine, according to findings published in Neurology. “Migraine and glaucoma have been linked through shared ...

The findings were published in the Neurology journal by Chien-Chih Chou and colleagues in a study titled Glaucoma Risk ...

Injectable migraine medications can help prevent migraine episodes and alleviate symptoms during an attack. Most are intended for migraine prevention, but some can help stop a migraine attack. Share ...

Key finding: Migraine patients on monoclonal antibody CGRP inhibitors had a 25% lower glaucoma risk over three years compared with other preventive therapies. Mechanism insight: The drugs may protect ...

Learn when to consider preventive migraine treatment, explore traditional and new therapies, and understand options like CGRP inhibitors, Botox, and neuromodulation.